Vimarsana
Biggest News Aggregation in the World

Page 49 - Director Interviews News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Interviews. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Interviews Today - Breaking & Trending Today

The Media Tech SPAC team present their experience and business ambitions ahead of London listing - Vimarsana News

The Media Tech SPAC team present their experience and business ambitions ahead of London listing

Media Tech SPAC Plc present their industry expertise and business plans to Proactive London ahead of their imminent listing in the British...

4D pharma updates on their phase II study of Blautix for the treatment of Irritable Bowel Syndrome - Vimarsana News

4D pharma updates on their phase II study of Blautix for the treatment of Irritable Bowel Syndrome

4d pharma plc's (LON:DDDD) Duncan Peyton talks to Proactive London about their additional positive results of a phase II study of Blautix for the...

Lithoquest Resources bulks up its portfolio by acquiring two district-scale gold projects in Ontario - Vimarsana News

Lithoquest Resources bulks up its portfolio by acquiring two district-scale gold projects in Ontario

Lithoquest Resources (CVE: LDI) CEO Bruce Counts joined Steve Darling from Proactive to share news the company has entered into an agreement with...

Water Tower Research highlights 'cleansed' energy groups that have repositioned post-bankruptcy - Vimarsana News

Water Tower Research highlights 'cleansed' energy groups that have repositioned post-bankruptcy

Water Tower Research Managing Director Jeff Robertson tells Proactive he recently published a report on bankruptcy cases in the energy sector entitled...

Global Cancer Technology to raise $9M through a Reg A+ offering to fund potential COVID treatment - Vimarsana News

Global Cancer Technology to raise $9M through a Reg A+ offering to fund potential COVID treatment

Global Cancer Technology Inc CEO John Clark tells Proactive the privately-held biopharmaceutical company will look to raise $9M through a Regulation A+...